Myanmar : The Next High Growth Country in Asia - Part 1

Myanmar at a glance :
1) Area – 676,578 sq km
2) Administrative divisions – 7 divisions (Ayeyarwaddy, Bago, Magway, Mandalay, Sagaing, Tanintharyi, Yangon) and 7 states (Chin, Kachin, Kayah, Kayin, Mon, Rakhine, Shan)
3) Population – 54.58 million (est mid-2012)
4) GDP – RM50.2bn nominal (est 2011)
5) Urbanization – 34% Major ethnic groups

Bamar – 68%
Shan – 9%
Karen – 7%
Rakhine – 4%
Chinese – 3%
Indian – 2%
Mon – 2%
Religion

Buddhist – 89%
Christian – 4%
Muslim – 4%
Others – 3%
6) Major exports – Natural gas, wood products, pulses, beans, fish, rice, clothing, jade and gems Major export partners (2010)
Thailand – 38.3%
India – 20.8%
China 12.9%
Japan – 5.2%

Special Situation Pick : Old Town Berhad

Old Town Berhad - This is one of new listed company in KLSE.

Why buy Old Town Coffee Share?
- This share is considered as high potential growth company, which is currently planning to expand in China & Indonesia rapidly. With experience management team, this company should able to do it within 3-5 years.
- Asia is a high growth region. Food & Beverage industry, should grow well in this region.
- It has special taste of South East Asia's coffee. There're some chinese from China, like this coffee much. So, it should tell us some hints about their successful rate in China.
- Competitive Advantages - This is hard to duplicate its product. Let's try Nestle White Coffee pack. It's a huge difference between Nestle White Cofffee 3-in-1 and Old Town White Coffee 3-in-1.

Next Big Thing in Asia : Cambodia...

It started to draw my attention on Cambodia when i read about Casino of Cambodia in WSJ.com.


One of Great Stock to buy :-
NagaCorp Ltd. (NagaCorp) operates a hotel and entertainment complex, NagaWorld, in Phnom Penh, the capital city of Cambodia. The Company has two segments: casino operations, and hotel and entertainment operations. The casino operations include all gaming activities at NagaWorld. The hotel and entertainment operations include the operations of leisure, hotel and entertainment activities. As of December 31, 2010, its casino complex, NagaWorld had hotel and entertainment facilities with a 506- room hotel, 12 food and beverage outlets, a nightclub, karaoke lounge and spa. NagaWorld’s facilities include 25,000 square meters of meeting and ballroom space; 6,500 square-meter ballroom; a 60-seat auditorium, and exhibition space. As of December 31, 2010, the number of slot stations was 1,032. During the year ended December 31, 2010, there were approximately 7,928 junket players, who visited its casino. In 2010, hotel and entertainment operations represented the non-gaming revenue in NagaWorld.


Where to buy:-
Hong Kong Stock Exchange.
 
Company Website
http://www.nagacorp.com/
 

"Stop Lynas" Campaign in Malaysia- Special Opportunity to invest Lynas Share in Australia Exchange

Lynas Limited

Profile
Lynas Corporation Limited creates fully integrated source of Rare Earths from mine through to market. The principal activities of the Company and its subsidiaries include planning, design and construction and operating a Concentration Plant in Western Australia; planning, design and construction of an Advanced Materials Processing Plant in Malaysia for the production and distribution of Rare Earth Oxides, and exploration and development of Rare Earths deposits. The Company’s principal activities also include exploration for other mineral resources. Its segments include Malaysia, Western Australia and other. In March 2011, the construction of the Concentration Plant in Western Australia was completed. The Company’s subsidiaries include Lynas Services Pty Ltd, Mt Weld Holdings Limited, Mt Weld Mining Pty Ltd, Mt Weld Rare Earths Pty Ltd, Lynas Malaysia Sdn Bhd, Lynas Africa Limited and Lynas Africa Holdings Pty Ltd.


Contact :-
Level 7 Level 7, 56 Pitt Street

SYDNEY, NSW 2000
Australia

+61-2-82597100 (Phone)
+61-2-82597199 (Fax)

Website :-
http://www.lynascorp.com/

Pharmaniaga plans expansion in Mideast, South-East Asia

Malaysia’s largest homegrown pharmaceutical group, Pharmaniaga plans to expand its market in the Middle East and South-East Asia, particularly Saudi Arabia, Indonesia, Myanmar and Vietnam. Chairman Tan Sri Lodin Wok Kamaruddin said the company was looking for growth opportunities in these countries, including through M&As.




Note:
1) Pharmaniaga is one of subsidary under Boustead Holdings Berhad. This will grow the Pharmaceutical division in Boustead for coming years.
2) Currently, we rated BUY for Boustead.

Boustead - The Next Giant in Malaysia

Boustead

-The Future Is Brighter Ahead
- FY11 core results (excluding exceptional) below HLIB and consensus expectations due to the heavy industry division (cost escalation and lapse in new contract) and lower plantation contribution in 4Q.
-4th interim single-tier dividend of 9 sen, making total of 29 sen, below our projection of 34.5 sen but not disappointing is add the dividend in species of Pharmaniaga shares.
- Despite the earnings disappointment, the new petrol vessel contract and maiden full year contribution from Pharmaniaga will revive earnings expansion from FY12 onwards.
- Rare stock that provide earnings growth and high yield.
- FY12-13 forecasts cut by 7-9% following the results.
- Maintain Buy.
-Target price raised to RM6.20 (10% discount to estimated SOP of RM6.89) from RM5.91, incorporating our higher TP for Affin, latest BHIC price and fine-tuning post FY11 results.

Four Stocks Tips from Anthony Bolton

3SBio: Diabetes is a big problem in China, Bolton explained, pointing out that in part this is due to the country's population becoming increasingly wealthy and altering its diet from rice-based to meat-based as a result.
3SBio is a US-listed company that profits from making drugs used to counteract the side-effects of kidney dialysis, a treatment offered to patients who are also experiencing kidney problems.
'The number of people being treated is increasing as there is more government finance and this [company] is a leader in the field,' Bolton explained. 'You're paying about 12x [earnings] for something that's growing well in the 20s, which I think is pretty attractive,' the manager added.



Kingdee, the new Sage: 'IT services is an area I'm very excited about,' Bolton said. 'Kingdee is in the business of accounting package software and looks very similar to a company in the UK called Sage,' Bolton said. Bolton first looked at Sage (SGE.L) as manager of the Fidelity UK Special Situations fund years ago when it was a fledgling enterprise. 'It is now a FTSE company, and has been a very good place to be,' he said. One of the things I look for is businesses like those I have invested in the west, but where you can buy them at a much earlier stage in their development.'


Wuxi Pharmatech: Wuxi is a laboratory and clinical trial company that works for large pharmaceuticals. Its clientele is largely international, and it offers its customers cheap but sophisticated scientific trials in China that can help keep margins down.



'Wuxi is a leader in that. The biggest company in that field is US-listed and is at 17x earnings. Wuxi is growing at about 15% - twice that of the leader - and trades at 12x,' Bolton said. 'You can buy faster growth at a cheaper valuation and that's the sort of thing that I really like in China.'



Rexlot The Chinese love of gambling is well known. '[There's] a welfare lottery, which raises money for welfare causes, and a sports lottery that raises money for sports. The total size of these is about two-thirds the size of Macau [the well known gambling haven], so it's a sizable business,' Bolton said. 'Rexlot is very interesting, on 8x earnings and growing at about 25% per annum. What they are going to introduce soon in China is the ability to gamble on your mobile phone and I think that could make even faster growth.'